Antiparkinson Agents (pharmacokinetics) < Antiparkinson Agents (pharmacology) < Antiparkinson Agents (standards)

Facettes :

List of bibliographic references indexed by Antiparkinson Agents (pharmacology)

Number of relevant bibliographic references: 72.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000250 (2015)	Ji Hyun Ko [États-Unis] ; Renata P. Lerner ; David Eidelberg	Effects of levodopa on regional cerebral metabolism and blood flow.
000303 (2015)	A Jon Stoessl	Central pharmacokinetics of levodopa: Lessons from imaging studies.
000542 (2014)	Peter Redgrave [Royaume-Uni] ; Nicolas Vautrelle ; Thomas Stafford	Interpretive conundrums when practice doesn't always make perfect.
000847 (2013)	E. D. Anderson ; F. B. Horak ; M. R. Lasarev ; J. G. Nutt	Performance of a motor task learned ON levodopa deteriorates when subsequently practiced OFF
000876 (2013)	Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. Fox	Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
000A39 (2013)	Tomoko Komagamine [Japon] ; Keisuke Suzuki ; Koichi Hirata	Darkening of white hair following levodopa therapy in a patient with Parkinson's disease.
001332 (2011)	Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]	The effect of drug treatment on neurogenesis in Parkinson's disease
001692 (2011)	Masahiko Kishi [Japon] ; Ryuji Sakakibara [Japon] ; Hitoshi Terada [Japon] ; Emina Ogawa [Japon] ; Terada Tateno [Japon]	Does levodopa affect metaiodobenzylguanidine myocardial accumulation in Parkinson's disease?
001723 (2011)	Thomas Müller [Allemagne] ; Siegfried Muhlack [Allemagne]	Cysteinyl‐glycine reduction as marker for levodopa‐induced oxidative stress in Parkinson's disease patients
001806 (2011)	Estelle Dellapina [France] ; Angélique Gerdelat-Mas [France] ; Fabienne Ory-Magne [France] ; Laure Pourcel [France] ; Monique Galitzky [France] ; Fabienne Calvas [France] ; Marion Simonetta-Moreau [France] ; Claire Thalamas [France] ; Pierre Payoux [France] ; Christine Brefel-Courbon [France]	Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
001B18 (2010)	Frazzitta Giuseppe [Italie] ; Bertotti Gabriella [Italie] ; Uccellini Davide [Italie] ; Maestri Roberto [Italie]	Parkinson's disease rehabilitation: A pilot study with 1 year follow up
001E04 (2010)	Suk Yun Kang [États-Unis, Corée du Sud] ; Toshiaki Wasaka [États-Unis] ; Ejaz A. Shamim [États-Unis] ; Sungyoung Auh [États-Unis] ; Yoshino Ueki [États-Unis] ; Grisel J. Lopez [États-Unis] ; Tetsuo Kida [États-Unis] ; Seung-Hyun Jin [États-Unis] ; Nguyet Dang [États-Unis] ; Mark Hallett [États-Unis]	Characteristics of the sequence effect in Parkinson's disease
001F84 (2009)	Birgitta Loref Lt [Suède] ; Göran Toss [Suède] ; Ann-Kathrine Granérus [Suède]	Weight loss, body fat mass, and leptin in Parkinson's disease
002042 (2009)	Diego Santos-García [Espagne] ; Mercedes Macías [Espagne] ; Miguel Llaneza [Espagne] ; Ángel Aneiros [Espagne]	Suicide following duodenal levodopa infusion for Parkinson's disease
002044 (2009)	David Weise [Allemagne] ; Reinhard Lorenz [Allemagne] ; Mira Schliesser [Allemagne] ; Andreas Schirbel [Allemagne] ; Karlheinz Reiners [Allemagne] ; Joseph Classen [Allemagne]	Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease
002227 (2009)	Jane E. Alty [Australie] ; Benjamin G. Clissold [Australie] ; Craig D. Mccoll [Australie] ; Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]	Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function
002235 (2009)	Bettina Pollok [Allemagne] ; Houssain Makhloufi [Allemagne] ; Markus Butz [Allemagne] ; Joachim Gross [Royaume-Uni] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Alfons Schnitzler [Allemagne]	Levodopa affects functional brain networks in parkinsonian resting tremor
002251 (2009)	Jan Herzog [Allemagne] ; Bettina Möller [Allemagne] ; Karsten Witt [Allemagne] ; Marcus O. Pinsker [Allemagne] ; Günther Deuschl [Allemagne] ; Jens Volkmann [Allemagne]	Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease
002293 (2009)	Yumi Sakakibara [Japon] ; Masato Asahina [Japon] ; Atsuya Suzuki [Japon] ; Takamichi Hattori [Japon]	Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy
002295 (2009)	Nathalie Chastan [France] ; Manh Cuong Do [France] ; Fabrice Bonneville [France] ; Frédéric Torny [France] ; Frédéric Bloch [France] ; G. W. Max Westby [France] ; Didier Dormont [France] ; Yves Agid [France] ; Marie-Laure Welter [France]	Gait and balance disorders in Parkinson's disease: Impaired active braking of the fall of centre of gravity
002331 (2009)	Elizabeth L. Stegemöller [États-Unis] ; Tanya Simuni [États-Unis] ; Colum Mackinnon [États-Unis]	Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (pharmacology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (pharmacology)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024